Articles > Popular publications > PR Newswire press releases > October-December 2009 > Tuesday, November 3

Article: Data for EntreMed's ENMD-2076 to Be Presented at the Upcoming AACR-NCI-EORTC Conference.

Article from:
PR Newswire
Article date:
November 3, 2009
Copyright

Data from the ENMD-2076 Phase 1 Leukemia Trial to be Included

ROCKVILLE, Md., Nov. 3 /PRNewswire-FirstCall/ -- EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced presentations for its Aurora A/angiogenic kinase inhibitor, ENMD-2076, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held November 15-19, 2009 in Boston, Massachusetts. Presentations are listed below. 

 
  (Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO ) 
 
  --  Poster Session: Monday, November 16, 2009 - 12:30 p.m. - 2:30 p.m. 
  Abstract No.: A106, "A ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO ...
PR Newswire;  May 15, 2009 ;     700+ words ... ... listed below. -- Poster Session: Friday, May ... pharmacokinetic study of ENMD-2076 administered ... Room, W415D. -- Poster Session: Saturday, May ... pharmacokinetic study of ENMD-1198 administered ... cancer." -- Poster Session: Sunday, May ...

Article: EntreMed, Inc. (Nasdaq: ENMD) Xtreme picks of the day!
M2 Presswire;  May 15, 2009 ;     700+ words ... ... listed below. -- Poster Session: Friday, May ... pharmacokinetic study of ENMD-2076 administered ... Room, W415D. -- Poster Session: Saturday, May ... pharmacokinetic study of ENMD-1198 administered ... cancer." -- Poster Session: Sunday, May ...

Article: EntreMed Presents ENMD-1198 Preclinical Data.
PR Newswire;  November 17, 2005 ;     700+ words ... ... novel tubulin binding agent, ENMD-1198. Results for the preclinical ... EntreMed scientists during a poster session at the combined American Association ... prnh/20010620/ENMDLOGO ) ENMD-1198, a new chemical entity ... Study results demonstrated that ENMD-1198 is an orally active ...

Article: Data for EntreMed's ENMD-2076 to Be Presented at the ...
Blood Weekly;  November 19, 2009 ;     427 words ... ... No.: A106, "A Phase 1 study of ENMD-2076 in patients with relapsed ... Halls C-D, 2nd floor. -- Poster Session: Monday, November 16, 2009 - 12 ... Aurora A and VEGFR2 kinase inhibitor, ENMD-2076, demonstrates synergistic ...

Article: EntreMed Commences ENMD 0995 Clinical Trial For Patients ...
PR Newswire;  November 13, 2002 ;     700+ words ... ... announced today that it has begun its ENMD 0995 clinical trial program for the treatment ... Mayo Clinic in Rochester, Minnesota, ENMD 0995, an EntreMed drug candidate that ... evaluate the safety and pharmacokinetics of ENMD 0995, as well as tumor response. Multiple ...

Article: EntreMed's ENMD-2076 Demonstrates Tumor Regression in ...
PR Newswire;  October 23, 2008 ;     700+ words ... ... Aurora A/angiogenesis kinase inhibitor, ENMD-2076. The data were presented by John ... cgi-bin/prnh/20010620/ENMDLOGO ) ENMD-2076 is a novel kinase inhibitor with ... linked to cancer and inflammatory diseases. ENMD-2076 demonstrated strong antitumor effects ...

Article: Entremed Presents Results of ENMD-2076 Phase 1 Study in ...
PR Newswire;  June 1, 2009 ;     700+ words ... ... Aurora A/angiogenic kinase inhibitor, ENMD-2076, at the American Society of Clinical ... cgi-bin/prnh/20010620/ENMDLOGO ) ENMD-2076, a small molecule, oral kinase ... patients who participated demonstrated that ENMD-2076 administered orally in daily doses ...

Article: EntreMed's ENMD-2076 Demonstrates Antitumor Activity in ...
PR Newswire;  June 2, 2008 ;     700+ words ... ... for its Aurora A/angiogenesis kinase inhibitor, ENMD-981693, the free base of ENMD-2076. The data were presented by Dr. Xiaojing ... com/cgi-bin/prnh/20010620/ENMDLOGO ) ENMD-2076 free base exhibited dose-dependent cytotoxicity ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives